This Cochrane review update of the effects of oral care measures in preventing nursing home-acquired pneumonia inlides 6 RCTs. Low-certainty evidence suggests that professional oral care may reduce mortality compared to usual care when measured at 24 months but evidence for other effects is inconclusive.
[read the full story...]
Amoxicillin and metronidazole as an adjunct to full-mouth scaling and root planing, malignant transformation on oral lichen planus and toothbrushing to prevent ventilator-associated pneumonia was out most popular blogs between October to December 2021.
[read the full story...]
This review of the effect of toothbrushing and chlorhexidine on the incidence of ventilator-associated pneumonia (VAP) in patients on mechanical ventilation included 7 RCTs. The findings showed that toothbrushing and chlorhexidine reduced VAP,length of stay and duration of ventilation. However the findings should be interpreted cautiously because of study quality.
[read the full story...]
This Cochrane review updated assessing the impact of oral health measures on the incidence of ventilator associated pneumonia (VAP) in critically ill patients receiving mechanical ventilation in intensive care includes 40 RCTs and suggests that Chlorhexidine mouthwash or gel, as part of oral health measures, probably reduces the incidence of developing VAP.
[read the full story...]
This review of whether toothbrushing-based oral health measures, performed in intensive care units, can reduce the risk of ventilator-associated pneumonia (VAP) included 12 RCTs with the findings suggesting a positive effect.
[read the full story...]
This Cochrane review of the effects of oral care on prevention of nursing home acquired pneumonia included 4 RCTs providing low quality evidence that oral care may reduce mortality.
[read the full story...]
38 RCTs were included in this Cochrane review update of oral health care in ventilated patients. High quality evidence was found to show that chlorhexidine mouthwash or gel reduces the risk of developing ventilator-associated pneumonia in critically ill patients from 25% to about 19%.
[read the full story...]
John Baker summarises the findings of a recent review of people with schizophrenia, bipolar disorder and depression. The study looks at the adverse effects on physical health of psychotropic drugs (antipsychotics, antidepressants and mood stabilisers).
[read the full story...]
17 RCTs were included in this review of oral care to reduce ventilator associated pneumonia (VAP). Evidence suggests it can reduce prevalence but not ICU mortality, length of ICU stay or duration of mechanical ventilation.
[read the full story...]
Because of a more favourable side effects profile (not necessarily clinical superiority), second-generation antipsychotics (SGAs) are today the most commonly used drugs to treat psychotic disorders such as schizophrenia (Jones et al., 2006). While rather frequent adverse reactions, including weight gain, diabetes or sedation, are largely recognised, recent studies point at increased risk of pneumonia [read the full story…]
